Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation

Authors:

Abstract
No abstract available
Funding Information
  • National Nature Science Foundation of China (81772778)
  • Shandong Province Key Research & Development Program (2017GSF18175)
  • Fundamental Research Funds (2082015QLMS44)

This publication has 33 references indexed in Scilit: